I want to take this opportunity to update each of you on Soliddd’s progress towards our next round of pre-clinical testing as we are also making strong progress on manufacturing SolidddVision glasses. In cooperation with our medical advisory board, we are nearing completion of the trial protocol. A qualifying test will be available on our website. Based on people’s answers to that test, we will be able to place those who qualify and want to take part in patient trials with an offer to take part.
More information will be in our next newsletter as we reach this important milestone towards bringing better vision for those who need it.
Neal Weinstock, CEO Soliddd
Soliddd Distributor for Australia and New Zealand Selected
Soliddd has closed an advance-purchase and distribution deal for Australia and New Zealand with AMD 3D Glasses Pty. Ltd.
Says founder Jim Pearce, "We're an Australian family company with experience in electric control systems, but with our medical conscience guided by a long interest and investment in genetic treatment for retinitis pigmentosa, in New York. We see AMD & Stargardt's also within reach of meaningful treatment from Soliddd’s bold use of 3D to provide more useful vision."
Soliddd Featured on French Medical News
Last month, Soliddd's CEO Neal Weinstock gave an interview to Le JT de l'Ophtalmologie, the leading French medical news program for vision care professionals.
Le JT de l'Ophtalmologie has become a trusted weekly broadcast watched by ophthalmologists, researchers, and clinicians across Europe. It covers innovation in imaging, surgery, therapeutics, major medical conferences, and regulatory developments.
Europe is a key part of Soliddd's strategic roadmap both for clinical collaboration and future patient access.
Soliddd a récemment été mis en lumière dans Le JT de l'Ophtalmologie, média majeur pour les professionnels de la vision en France et en Europe. Notre cofondateur et CEO, Neal Weinstock, y a présenté nos lunettes SolidddVision.
Le JT de l'Ophtalmologie est un rendez-vous hebdomadaire de référence dédié à la santé visuelle, suivi par ophtalmologues, chercheurs et professionnels de santé. Il traite des dernières avancées industrielles, des innovations technologiques, des congrès médicaux, ainsi que de sujets scientifiques de fond, à travers interviews, reportages et analyses.
L'Europe s'inscrit au cœur de notre stratégie, où nous avons pour ambition de rendre nos lunettes accessibles au plus grand nombre et de développer des partenariats scientifiques.
Earlier this spring, Soliddd was featured in L’Observatoire Optic 2000, a French media outlet dedicated to exploring how evolving lifestyles impact vision and hearing. The platform regularly features expert insights, new research, and emerging trends shaping the future of health and wellness.
The English translated article is available here, and the original French version can be found here.
Soliddd and SolidddVision are trademarks of Soliddd Corp.
All other trade names are the property of their respective owners.
